Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumor in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost the global cancer diagnostic market growth. For instance, according to WHO (World Health Organization) cancer is the foremost cause of mortality across the world, which holding account around 9.6 million deaths in 2018. Furthermore, continuous growth of the healthcare and diagnostics sector will positively contribute the market growth during this forecast period. Also, rise in collaborative and independent government as well as private sector initiatives will drive the market growth. Moreover, increase in technological advancements in target disease screening tests will propel the market growth.
However, high capital investments and low benefit cost ratio for biomarkers is the major challenging factor which is expected to hinder the global cancer diagnostics market growth. Furthermore, high cost of diagnostic imaging systems will hamper the market growth during this analysis period.
Global Cancer Diagnostics Market is segmented into diagnostic type such as Diagnostic Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, and Others. Further, market is segmented into application such as Breast Cancer, Lung Cancer, Cervical Cancer, Kidney Cancer, Pancreatic Cancer, and Others.
Also, Global Cancer Diagnostics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa
Various key players are discussed in this report such as Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., Siemens Healthcare, and C.R. Bard, Inc.
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5.1 Y-o-Y Growth Comparison, By Diagnostic Type
5.2 Global Cancer Diagnostics Market Share Analysis, By Diagnostic Type
5.3 Global Cancer Diagnostics Market Size and Forecast, By Diagnostic Type
5.3.1 Diagnostic Imaging Tests
5.3.2 Biopsy and Cytology Tests
5.3.3.Tumor Biomarkers
5.3.4. Others
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Cancer Diagnostics Market Share Analysis, By Application
6.3 Global Cancer Diagnostics Market Size and Forecast, By Application
6.3.1 Breast Cancer
6.3.2 Lung Cancer
6.3.3 Cervical Cancer
6.3.4. Kidney Cancer
6.3.5. Pancreatic Cancer
6.3.6. Others
7.1 Global Cancer Diagnostics Market Share Analysis, By Region
7.2 Global Cancer Diagnostics Market Share Analysis, By Region
7.3 Global Cancer Diagnostics Market Size and Forecast, By Region
8.1 Introduction
8.2 North America Cancer Diagnostics Market Share Analysis, By Diagnostic Type
8.3 North America Cancer Diagnostics Market Size and Forecast, By Application
8.4 North America Cancer Diagnostics Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9.1 Introduction
9.2 Europe Cancer Diagnostics Market Share Analysis, By Diagnostic Type
9.3 Europe Cancer Diagnostics Market Size and Forecast, By Application
9.4 Europe Cancer Diagnostics Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10.1 Introduction
10.2 Asia Pacific Cancer Diagnostics Market Share Analysis, By Diagnostic Type
10.3 Asia Pacific Cancer Diagnostics Market Size and Forecast, By Application
10.4 Asia Pacific Cancer Diagnostics Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11.1 Introduction
11.2 Latin America Cancer Diagnostics Market Share Analysis, By Diagnostic Type
11.3 Latin America Cancer Diagnostics Market Size and Forecast, By Application
11.4 Latin America Cancer Diagnostics Market Size and Forecast, By Country
12.1 Introduction
12.2 Middle East Cancer Diagnostics Market Share Analysis, By Diagnostic Type
12.3 Middle East Cancer Diagnostics Market Size and Forecast, By Application
12.4 Middle East Cancer Diagnostics Market Size and Forecast, By Country
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
